SEC Form 4 · accession 0001104659-16-151611
CRISPR Therapeutics AG · CRSP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Oct 24, 2016
Accepted (ET)
Oct 24, 2016 · 2:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001674416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Oct 24, 2016 | C | 744,380 | — | A | 744,380 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred SharesF1 | — | Oct 24, 2016 | C | 744,380 | D | — | — | Common Shares | 744,380 | 0 | D |
Explanation of responses
- F1The Series B Convertible Preferred Shares converted into common shares on a one-for-one basis and had no expiration date.